I reported previously (Feb 2015) on the recovery from muscle injury of hip-replacement patients treated with PLX-PAD stem cells from Israel’s Pluristem. Follow-up data has now confirmed the results and expanded Phase III trials are being supported by the European Horizon 2020 program.

http://www.pluristem.com/wp-content/uploads/2018/10/Muscle_publication_final_isa.pdf